133 related articles for article (PubMed ID: 31814301)
1. Self-Albumin Camouflage of Carrier Protein Prevents Nontarget Antibody Production for Enhanced LDL-C Immunotherapy.
Ji H; Wu G; Li Y; Wang K; Xue X; You S; Wu S; Ren T; He B; Shi X
Adv Healthc Mater; 2020 Jan; 9(1):e1901203. PubMed ID: 31814301
[TBL] [Abstract][Full Text] [Related]
2. Development of vaccine for dyslipidemia targeted to a proprotein convertase subtilisin/kexin type 9 (PCSK9) epitope in mice.
Kawakami R; Nozato Y; Nakagami H; Ikeda Y; Shimamura M; Yoshida S; Sun J; Kawano T; Takami Y; Noma T; Rakugi H; Minamino T; Morishita R
PLoS One; 2018; 13(2):e0191895. PubMed ID: 29438441
[TBL] [Abstract][Full Text] [Related]
3. Long-term generation of antiPCSK9 antibody using a nanoliposome-based vaccine delivery system.
Momtazi-Borojeni AA; Jaafari MR; Badiee A; Sahebkar A
Atherosclerosis; 2019 Apr; 283():69-78. PubMed ID: 30797988
[TBL] [Abstract][Full Text] [Related]
4. Vaccine draining lymph nodes are a source of antigen-specific B cells.
Pero SC; Sun YJ; Shukla GS; Carman CL; Krag CC; Teuscher C; Krementsov DN; Krag DN
Vaccine; 2017 Mar; 35(9):1259-1265. PubMed ID: 28161423
[TBL] [Abstract][Full Text] [Related]
5. Hybrid nanoparticle-based nicotine nanovaccines: Boosting the immunological efficacy by conjugation of potent carrier proteins.
Zhao Z; Hu Y; Harmon T; Pentel PR; Ehrich M; Zhang C
Nanomedicine; 2018 Jul; 14(5):1655-1665. PubMed ID: 29719216
[TBL] [Abstract][Full Text] [Related]
6. Antibody Production with Synthetic Peptides.
Lee BS; Huang JS; Jayathilaka LP; Lee J; Gupta S
Methods Mol Biol; 2016; 1474():25-47. PubMed ID: 27515072
[TBL] [Abstract][Full Text] [Related]
7. Comparison of antibody titers after immunization with monovalent or tetravalent KLH conjugate vaccines.
Ragupathi G; Cappello S; Yi SS; Canter D; Spassova M; Bornmann WG; Danishefsky SJ; Livingston PO
Vaccine; 2002 Jan; 20(7-8):1030-8. PubMed ID: 11803062
[TBL] [Abstract][Full Text] [Related]
8. Selective roles of thymus-derived lymphocytes in the antibody response. I. Differential suppressive effect of carrier-primed T cells on hapten-specific IgM and IgG antibody responses.
Tada T; Takemori T
J Exp Med; 1974 Jul; 140(1):239-52. PubMed ID: 4134784
[TBL] [Abstract][Full Text] [Related]
9. Vaccine strategies for lowering LDL by immunization against proprotein convertase subtilisin/kexin type 9.
Chackerian B; Remaley A
Curr Opin Lipidol; 2016 Aug; 27(4):345-50. PubMed ID: 27389630
[TBL] [Abstract][Full Text] [Related]
10. Peptide-based anti-PCSK9 vaccines - an approach for long-term LDLc management.
Galabova G; Brunner S; Winsauer G; Juno C; Wanko B; Mairhofer A; Lührs P; Schneeberger A; von Bonin A; Mattner F; Schmidt W; Staffler G
PLoS One; 2014; 9(12):e114469. PubMed ID: 25474576
[TBL] [Abstract][Full Text] [Related]
11. Antibodies to keyhole limpet hemocyanin cross-react with an epitope on the polysaccharide capsule of Cryptococcus neoformans and other carbohydrates: implications for vaccine development.
May RJ; Beenhouwer DO; Scharff MD
J Immunol; 2003 Nov; 171(9):4905-12. PubMed ID: 14568972
[TBL] [Abstract][Full Text] [Related]
12. Intranasal Peptide-Based FpvA-KLH Conjugate Vaccine Protects Mice From
Sen-Kilic E; Blackwood CB; Boehm DT; Witt WT; Malkowski AC; Bevere JR; Wong TY; Hall JM; Bradford SD; Varney ME; Damron FH; Barbier M
Front Immunol; 2019; 10():2497. PubMed ID: 31708925
[No Abstract] [Full Text] [Related]
13. Regulation of immune response by preadministration of cells briefly pulsed with antigen in vitro. I. Suppression of IgE antibody response by antigen pulsed spleen cells.
Yokomuro K; Mabuchi A; Saizawa M; Kojima N; Rosenthal AS; Kimura Y
Int Arch Allergy Appl Immunol; 1982; 69(2):98-108. PubMed ID: 7049962
[TBL] [Abstract][Full Text] [Related]
14. Epitope-specific regulation. I. Carrier-specific induction of suppression for IgG anti-hapten antibody responses.
Herzenberg LA; Tokuhisa T
J Exp Med; 1982 Jun; 155(6):1730-40. PubMed ID: 6176665
[TBL] [Abstract][Full Text] [Related]
15. The next-generation nicotine vaccine: a novel and potent hybrid nanoparticle-based nicotine vaccine.
Hu Y; Smith D; Frazier E; Hoerle R; Ehrich M; Zhang C
Biomaterials; 2016 Nov; 106():228-39. PubMed ID: 27569868
[TBL] [Abstract][Full Text] [Related]
16. Improvement and optimization of a T-cell-dependent antibody response (TDAR) method for BALB/c mice using keyhole limpet hemocyanin (KLH) as specific antigen.
Chang P; Huang L; Huang M; Tian S; Yang Z
J Immunotoxicol; 2019 Dec; 16(1):149-154. PubMed ID: 31290717
[TBL] [Abstract][Full Text] [Related]
17. Humoral immune response against proteophosphoglycan surface antigens of Entamoeba histolytica elicited by immunization with synthetic mimotope peptides.
Melzer H; Baier K; Felici F; von Specht BU; Wiedermann G; Kollaritsch H; Wiedermann U; Duchêne M
FEMS Immunol Med Microbiol; 2003 Jul; 37(2-3):179-83. PubMed ID: 12832123
[TBL] [Abstract][Full Text] [Related]
18. Stimulatory effects of B7-related protein-1 on cellular and humoral immune responses in mice.
Guo J; Stolina M; Bready JV; Yin S; Horan T; Yoshinaga SK; Senaldi G
J Immunol; 2001 May; 166(9):5578-84. PubMed ID: 11313397
[TBL] [Abstract][Full Text] [Related]
19. Induction of immune suppression in the chick by an optimal dose of an immunizing antigen in the presence of its specific maternal antibody.
Elazab MF; Fukushima Y; Fujita Y; Horiuchi H; Matsuda H; Furusawa S
J Vet Med Sci; 2010 Mar; 72(3):257-62. PubMed ID: 20035117
[TBL] [Abstract][Full Text] [Related]
20. The in vivo elimination of CD4+ T cells prevents the induction but not the expression of carrier-induced epitopic suppression.
Leclerc C; Schutze MP; Deriaud E; Przewlocki G
J Immunol; 1990 Sep; 145(5):1343-9. PubMed ID: 1696595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
